Sharmila Joshi, Head of Equity, Peerless Securities Ltd. is of the view that one can sell Orchid Chemicals,
Joshi told CNBC-TV18, “For me Orchid Chemicals is a sell. This is one of those momentum kind of plays which really speaking is very difficult to predict which way the stock is going to move. So if you want a slightly more stable pharma play I would shift to Ipca Laboratories. That is a stock that I would be more comfortable owning in my portfolio. So I would really recommend an exit.”
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!